VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 75 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,214,000 | -8.5% | 20,697,286 | +29.0% | 3.59% | +11.3% |
| Q1 2022 | $19,899,000 | -36.4% | 16,047,286 | 0.0% | 3.22% | -24.6% |
| Q4 2021 | $31,292,000 | -28.8% | 16,047,286 | 0.0% | 4.28% | -24.3% |
| Q3 2021 | $43,970,000 | -13.0% | 16,047,286 | 0.0% | 5.65% | -7.9% |
| Q2 2021 | $50,549,000 | +45.6% | 16,047,286 | -1.6% | 6.13% | +62.8% |
| Q1 2021 | $34,725,000 | +91.2% | 16,302,596 | +74.2% | 3.77% | +41.1% |
| Q4 2020 | $18,158,000 | – | 9,360,000 | – | 2.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|